Pliant Therapeutics, Inc. (PLRX) Tops Q3 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts PLRX Hot Sheet
Join SI Premium – FREE
Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q3 EPS of ($0.43), $0.13 better than the analyst estimate of ($0.56).
For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loar Holdings Inc. (LOAR) Reports Q3 EPS of $0.39 ; Offers Guidance
- GCI Liberty, Inc. (GLIBA) Tops Q3 EPS by 94c
- Materion Corp. (MTRN) PT Lowered to $232; KeyBanc: 'We would be aggressive buyers'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
